Science Explorer Back to mapMap

Most cited papers in Coagulation, Bradykinin, Polyphosphates, and Angioedema

Coagulation, Bradykinin, Polyphosphates, and Angioedema

What are the most cited papers in Coagulation, Bradykinin, Polyphosphates, and Angioedema?

The most cited paper in Coagulation, Bradykinin, Polyphosphates, and Angioedema is "TOR Signaling in Growth and Metabolism" (Stephan Wullschleger, Robbie Loewith, Michael N. Hall, 2006), with 5,827 citations. Next come "A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9" (3,177) and "A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis" (3,128).

Showing 50 of 98 papers. Every paper with more than 835 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 TOR Signaling in Growth and Metabolism Stephan Wullschleger, Robbie Loewith, Michael N. Hall · Cell Open access Feb 2006 5,827
2 A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9 Mary Donoghue, F. Hsieh, Elizabeth Baronas et al. · Circulation Research Open access Sep 2000 3,177
3 A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis SR Poort, FR Rosendaal, PH Reitsma et al. · Blood 15 Nov 1996 3,128
4 Complement Mark J. Walport · New England Journal of Medicine 5 Apr 2001 2,952
5 Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton Dos D. Sarbassov, Siraj Mahamed Ali, Do‐Hyung Kim et al. · Current Biology Open access Jul 2004 2,701
6 Thrombin signalling and protease-activated receptors Shaun R. Coughlin · Nature Sep 2000 2,497
7 Rho GTPases and signaling networks Linda Van Aelst, Crislyn D’Souza‐Schorey · Genes & Development Open access 15 Sep 1997 2,385
8 Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF Pamela J. Keck, Scott D. Hauser, Gwen G. Krivi et al. · Science 8 Dec 1989 2,077
9 Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms Thorsten Klampfl et al. · New England Journal of Medicine Open access 10 Dec 2013 2,021
10 Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Björn Dahlbäck, Martin Carlsson, Peter J. Svensson · Proceedings of the National Academy of Sciences Open access Feb 1993 1,990
11 Mechanisms of Thrombus Formation Bruce Furie, Barbara C. Furie · New England Journal of Medicine 27 Aug 2008 1,925
12 The coagulation cascade: initiation, maintenance, and regulation Earl W. Davie, Kazuo Fujikawa, Walter Kisiel · Biochemistry Oct 1991 1,823
13 Acromegaly: An Endocrine Society Clinical Practice Guideline Laurence J. Katznelson, Edward R. Laws, Shlomo K. Melmed et al. · The Journal of Clinical Endocrinology & Metabolism Open access 30 Oct 2014 1,816
14 Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura Gallia G. Levy, William C. Nichols, Eric C.‐Y. Lian et al. · Nature Open access 4 Oct 2001 1,764
15 Bioregulation of kinins: kallikreins, kininogens, and kininases. K. D. Bhoola, Carlos D. Figueroa, Katrina H. Worthy · Pharmacological Reviews Mar 1992 1,756
16 Polypeptide with Broad Biological Activity: Isolation from Small Intestine Sami I. Said, Viktor Mutt · Science 18 Sep 1970 1,603
17 Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone Carsten Jonat, Hans J. Rahmsdorf, Kun-Koo Park et al. · Cell Sep 1990 1,600
18 Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome Christophe M. Legendre et al. · New England Journal of Medicine Open access 5 Jun 2013 1,590
19 Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction Hsin‐Fang Yang‐Yen, Jean‐Claude Chambard, Yu-Lin Sun et al. · Cell Sep 1990 1,589
20 Venous thrombosis: a multicausal disease FR Rosendaal · The Lancet Open access Apr 1999 1,583
21 The urokinase-type plasminogen activator system in cancer metastasis: A review Peter A. Andreasen, Lars Kjøller, Lise Christensen et al. · International Journal of Cancer Open access 3 Jul 1997 1,560
22 The Pharmacology and Management of the Vitamin K Antagonists Jack Ansell, Jack Hirsh, Leon Poller et al. · CHEST Journal Sep 2004 1,536
23 STUDIES ON INFLAMMATION Guido Majno, George E. Palade · The Journal of Cell Biology Open access Dec 1961 1,531
24 Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 Kimberly A. McAllister, K.M. Grogg, David Wayne Johnson et al. · Nature Genetics Open access Dec 1994 1,507
25 Regulation of matrix metalloproteinase expression in tumor invasion Jukka K. Westermarck, Veli‐Matti Kähäri · The FASEB Journal May 1999 1,501
26 ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM Marek Witold Radomski, Richard M. J. Palmer, Salvador Moncada · The Lancet Nov 1987 1,449
27 Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis Morie Abraham Gertz, Ray Comenzo, Rodney H. Falk et al. · American Journal of Hematology 2005 1,438
28 Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling Xiaofeng Li, Yazhou Zhang, Heeseog Kang et al. · Journal of Biological Chemistry Open access 19 Mar 2005 1,376
29 Polymyalgia Rheumatica and Giant-Cell Arteritis Carlo Salvarani, Fabrizio Cantini, Luigi Boiardi et al. · New England Journal of Medicine Open access 25 Jul 2002 1,349
30 Modulation of endothelial cell hemostatic properties by tumor necrosis factor. Peter P. Nawroth, D Stern · The Journal of Experimental Medicine Open access Mar 1986 1,324
31 Synthesis of Antihemophilic Factor Antigen by Cultured Human Endothelial Cells ERIC A. JAFFE, Leon W. Hoyer, Ralph L. Nachman · Journal of Clinical Investigation Open access Nov 1973 1,292
32 Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin Geneviève Nguyen, Françoise Delarue, Céline Burcklé et al. · Journal of Clinical Investigation Open access Jun 2002 1,282
33 Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study Ted Koster, Jan Paul Vandenbroucke, FR Rosendaal et al. · The Lancet Dec 1993 1,268
34 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides Kallenberg, C. G.M. et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill) Open access Nov 2020 1,268
35 The molecular basis of blood coagulation Bruce Furie, Barbara C. Furie · Cell May 1988 1,254
36 The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria Torsten Zuberbier et al. · Allergy Open access 18 Sep 2021 1,253
37 Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases Steffen Maßberg, Lenka Grahl, Marie‐Luise von Bruehl et al. · Nature Medicine Aug 2010 1,220
38 EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis Max M. Yates et al. · Annals of the Rheumatic Diseases Open access 24 Jun 2016 1,210
39 LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETS Jacques Benveniste, Peter M. Henson, Charles G. Cochrane · The Journal of Experimental Medicine Open access Dec 1972 1,208
40 Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Thomas A. Drake, James H. Morrissey, Thomas S. Edgington · PubMed Open access May 1989 1,199
41 International consensus guidance for management of myasthenia gravis Donald B. Sanders, Gil I. Wolfe, Michael G Benatar et al. · Neurology Open access 29 Jun 2016 1,190
42 Metalloproteinase inhibitors: biological actions and therapeutic opportunities Andrew Howard Baker, Dylan R. Edwards, Gillian Murphy · Journal of Cell Science Oct 2002 1,184
43 Proteinase-activated Receptors Scott R. Macfarlane, Michael J. Seatter, Toru Kanke et al. Book chapter 10 Jul 2006 1,141
44 Resistance to Activated Protein C as a Basis for Venous Thrombosis Peter J. Svensson, Björn Dahlbäck · New England Journal of Medicine Open access 24 Feb 1994 1,130
45 New Fundamentals in Hemostasis Henri H. Versteeg, Johan W. M. Heemskerk, Marcel M Levi et al. · Physiological Reviews Review 2013 1,126
46 Inorganic Polyphosphate: A Molecule of Many Functions Arthur Kornberg, Narayana N. Rao, Dana Ault-Riché · Annual Review of Biochemistry Review Jun 1999 1,120
47 Rational design and characterization of a Rac GTPase-specific small molecule inhibitor Yuan Gao, J. Bradley Dickerson, Fukun Guo et al. · Proceedings of the National Academy of Sciences Open access 5 May 2004 1,120
48 A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets Fiona Francis et al. · Nature Genetics Oct 1995 1,118
49 A Mutation in the TRPC6 Cation Channel Causes Familial Focal Segmental Glomerulosclerosis Michelle P. Winn, Peter J. Conlon, Kelvin L. Lynn et al. · Science 6 May 2005 1,106
50 Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria Marcus Maurer, Karin E. Rosén, Hsin-Ju Hsieh et al. · New England Journal of Medicine Open access 24 Feb 2013 1,105

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.